John Neal
Senior Partner, EVERSANA MANAGEMENT CONSULTING
Expertise:
John brings over 30 of pharmaceutical, biotechnology, device, and diagnostic industry leadership experience in commercialization, market access, reimbursement, HEOR, government affairs, sales, and marketing.
John has an extensive background in life sciences management consulting focused on the disciplines of market access, pricing, payer and purchaser contracting, value dossier creation, channel and distribution, coding, and reimbursement. John has therapeutic area expertise in the areas of Vaccines, Cell and Gene Therapy, and Specialty Biologics.
Before joining EVERSANA, John spent 5 years in market access, payer strategy, launch planning, and payer marketing at Avalere Health, leading its Cell and GeneTherapy practice area. Before Consulting Management and Leadership, John was on the manufacturer side with positions of increasing commercial leadership within the areas of Sales, Marketing, and Market Access with GSK, Novartis, and EMD Serono, where he led the payer function.
John holds a BSc in Chemistry from the University of Illinois and an MBA from Drake University.
Articles by John Neal
Your Market Access Model is Bleeding Value
Your market access model may be quietly eroding more value than you realize. In today’s environment, up to 50% of commercial value is lost due to market access challenges. As policy pressures from the IRA, evolving MFN frameworks, and sweeping PBM reform reshape the landscape—compressing both the pricing ceiling and the commercial window for branded […]
Webinar Recording | From MFPs to MFN: Navigating the New Rules of Drug Pricing in 2026
In this recent webinar, experts John Neal, Katya Svoboda, and David Byram examine the major policy shifts transforming the U.S. drug pricing landscape—including the accelerating impact of MFN models, evolving MFPs, PBM transparency reforms, and the growth of direct-to-patient models. The discussion highlights how these policies intersect, the risks and opportunities they create for manufacturers, […]